Topics

HHS sues Gilead for refusing to reach a licensing deal over patents for HIV prevention pills https://www.statnews.com/pharmalot/2019/11/07/hhs-gilead-hiv-prevention-patents-lawsuit/ … via @statnews

10:31 EST 7 Nov 2019 | STAT

HHS sues Gilead for refusing to reach a licensing deal over patents for HIV prevention pills https://www.statnews.com/pharmalot/2019/11/07/hhs-gilead-hiv-prevention-patents-lawsuit/ … via

Original Article: HHS sues Gilead for refusing to reach a licensing deal over patents for HIV prevention pills https://www.statnews.com/pharmalot/2019/11/07/hhs-gilead-hiv-prevention-patents-lawsuit/ … via @statnews

NEXT ARTICLE

More From BioPortfolio on "HHS sues Gilead for refusing to reach a licensing deal over patents for HIV prevention pills https://www.statnews.com/pharmalot/2019/11/07/hhs-gilead-hiv-prevention-patents-lawsuit/ … via @statnews"

Quick Search

Relevant Topics

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...

Human Immuno Deficiency Virus (HIV)
Human Immunodeficiency Virus (HIV), the causative agent of AIDS. The Human Immunodeficiency Virus, more commonly known as HIV, is a member of the lentivirus sub-set of the retrovirus family of pathogens. It causes AIDS, or Acquired Immuno Deficiency Sy...